Company intelligence / Profile preview

Prescience InSilico

Bengaluru, Karnataka, Indiaprescience.in ↗

Ownership: Private
Development stage: Other

Overview

Prescience InSilico has developed the PRinS3 platform to accelerate early-stage drug discovery using AI-driven software that integrates physics-based modeling, molecular dynamics simulations, machine learning methods, and high-performance computing. The company focuses on reducing time-to-candidate selection by enabling rapid virtual screening and property prediction before synthesis. No clinical results are reported as the company operates primarily at the preclinical/computational stage.

Therapeutic areas: Other
Modalities: Small molecules (via computational drug design and screening)
Industry: Drug Discovery Services

Partnerships

Not publicly disclosed; collaborates with academia and industry clients for custom projects.

Beyond the preview

Go deeper on Prescience InSilico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prescience InSilico.

Explore the full profile